Article info

Download PDFPDF
Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma

Authors

  1. Correspondence to Professor Steffen Heegaard, Department of Pathology, Eye Section, Rigshospitalet, Copenhagen 2100, Denmark; sthe{at}sund.ku.dk
View Full Text

Citation

Kirkegaard MK, Minderman M, Sjö LD, et al
Prevalence and prognostic value of MYD88 and CD79B mutations in ocular adnexal large B-cell lymphoma: a reclassification of ocular adnexal large B-cell lymphoma

Publication history

  • Received May 2, 2021
  • Accepted October 10, 2021
  • First published October 27, 2021.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.